| Staurosporine | IC50 | 5089.0 [1] |
| Seliciclib | IC50 | 34000.0 [1] |
| Olomoucine | IC50 | 25000.0 [1], 30000.0 [2] |
| Doramapimod | IC50 | 20000.0 [1], 30000.0 [2] |
| Purvalanol B | IC50 | 3300.0 [1], 3333.0 [2] |
| Purvalanol A | IC50 | 9000.0 [1] |
| CID 24866313 | IC50 | 4.0 [1], 8.0 [2] |
| 5-(2-Phenylpyrazolo[1,5-A]pyridin-3-YL)-1H-pyrazolo[3,4-C]pyridazin-3-amine | Ki | 310.0 [1] |
| Tanzisertib | IC50 | 480.0 [1] |
| Sorafenib | IC50 | 18.1 [1] |
| (Z)-3-Amino-3-(4-aminophenylthio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile | IC50 | 10000.0 [1] |
| Kenpaullone | IC50 | 20000.0 [1] |
| Tak-285 | IC50 | 10000.0 [1] |
| 1-(2,4-Difluorophenyl)-3-(4-(6,7-dimethoxyquinolin-4-yloxy)-2-fluorophenyl)urea | IC50 | 10000.0 [1] |
| Amg-458 | IC50 | 100000.0 [1] |
| CID 46209401 | IC50 | 10000.0 [1] |
| CID 6918852 | Ki | 50000.0 [1] |
| Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]- | IC50 | 10000.0 [1] |
| 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 18000.0 [1] |
| JNK Inhibitor V | IC50 | 10000.0 [1] |
| JNK Inhibitor VIII | Ki | 9200.0 [1] |
| Bms-509744 | IC50 | 50000.0 [1] |
| Ravoxertinib | IC50 | 1.2 [1] |
| Pyrimidone, 22 | IC50 | 100000.0 [1] |
| (2S,3S)-3-((7-(Benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)butane-1,2,4-triol | IC50 | 3730.0 [1] |
| 3-Phenyl-1H-benzofuro[3,2-c]pyrazole | IC50 | 10000.0 [1] |
| 2-(4-Fluoroanilino)-5-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-methylpyrimidin-4-one | IC50 | 100000.0 [1] |
| 1-[2-Fluoro-4-(5-methylpyrrolo[3,2-d]pyrimidin-4-yl)oxyphenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 10000.0 [1] |
| N-[4-(6,7-Dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1,5-dimethyl-3-oxo-2-phenylpyrazole-4-carboxamide | IC50 | 25000.0 [1] |
| MEK Inhibitor II | IC50 | 82900.0 [1] |
| N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)urea | IC50 | 10000.0 [1] |
| CID 46203864 | IC50 | 980.0 [1] |
| (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 1000.0 [1] |
| CID 58282870 | IC50 | 20.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 9200.0 [1] |
| Lck Inhibitor | IC50 | 100000.0 [1] |
| 1-(2,6-Dichlorophenyl)-5-(2,4-difluorophenyl)-7-(4-piperidinyl)-1,2,3,4-tetrahydroquinazoline-2-one | IC50 | 10000.0 [1] |
| 2,2-Dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-1-[(1R)-1-phenylethyl]-3H-quinazolin-4-one | IC50 | 1000.0 [1] |
| Methyl 6-bromo-2-[(4-methylsulfonylphenyl)methyl]-1-oxo-4-phenylisoquinoline-3-carboxylate | IC50 | 11000.0 [1] |
| Meridianin E | IC50 | 100000.0 [1] |
| (E)-3-[4-[[[8-Carbamoyl-7-(3,5-dimethoxyanilino)imidazo[1,2-c]pyrimidin-5-yl]amino]methyl]phenyl]prop-2-enoic acid | IC50 | 10000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 9200.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 9200.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 9200.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 9200.0 [1] |
| 3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 10000.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| 3-[[[5-[1-(4-Methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazol-2-yl]thio]methyl]benzonitrile | IC50 | 10000.0 [1] |
| [4-[[4-(3H-Benzimidazol-5-ylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-2-(cyanoamino)phenyl]cyanamide | IC50 | 300.0 [1] |
| 2-N-(3H-Benzimidazol-5-yl)-4-N-(2-chlorophenyl)-5-(trifluoromethyl)pyrimidine-2,4-diamine | IC50 | 1000.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| 3-[1-(2-Imidazol-1-ylethyl)pyrazolo[3,4-b]pyridin-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 40000.0 [1] |
| 4-(4-Fluorophenyl)-N-[4-[3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl]oxyphenyl]phthalazin-1-amine | IC50 | 25000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| (3S)-N-[3-(4-Fluorophenyl)-1H-indazol-5-yl]-3-methylsulfanyl-1-[2-oxo-2-[4-(4-pyrimidin-2-ylphenyl)piperazin-1-yl]ethyl]pyrrolidine-3-carboxamide | IC50 | 25.0 [1] |
| Erk2 IN-1 | IC50 | 41.0 [1] |
| N-[4-Chloro-3-(pyridin-3-yloxymethyl)phenyl]-3-fluoro-5-morpholin-4-ylbenzamide | IC50 | 10000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| Tilfrinib | IC50 | 10000.0 [1] |
| [4-Amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone | IC50 | 100000000.0 [1] |
| Ethyl (E)-3-[4-[[[8-carbamoyl-7-(3,5-dimethoxyanilino)imidazo[1,2-c]pyrimidin-5-yl]amino]methyl]phenyl]prop-2-enoate | IC50 | 10000.0 [1] |
| 7-(Morpholin-4-ylmethyl)-3-[2-(pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 10000.0 [1] |
| (4S,6Z,9S,10R,12E)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione | IC50 | 1400.0 [1] |
| 3-[5-Chloro-4-[(2,4-difluorophenyl)methoxy]-6-oxopyrimidin-1-yl]-N-(2-hydroxyethyl)-4-methylbenzamide | IC50 | 10000.0 [1] |
| 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 2900.0 [1] |
| 2-[3-[3-(4-Methylpiperazin-1-yl)propoxy]phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 10000.0 [1] |
| 2-[4-[(Z)-[1-(3-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-phenylacetamide | IC50 | 65.0 [1] |
| 2-[4-[(Z)-[1-(3-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-(2-methylphenyl)acetamide | IC50 | 43.0 [1] |
| 2-[4-[(Z)-[1-(3-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-(3-methylphenyl)acetamide | IC50 | 20.0 [1] |
| 2-[4-[(Z)-[1-(3-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-(4-methylphenyl)acetamide | IC50 | 25.0 [1] |
| N-(2-Methoxyphenyl)-2-[4-[(Z)-[1-(3-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 46.0 [1] |
| N-(3-Methoxyphenyl)-2-[4-[(Z)-[1-(3-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 57.0 [1] |
| N-(4-Methoxyphenyl)-2-[4-[(Z)-[1-(3-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 76.0 [1] |
| N-(2-Chlorophenyl)-2-[4-[(Z)-[1-(3-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 87.0 [1] |
| N-(3-Chlorophenyl)-2-[4-[(Z)-[1-(3-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 89.0 [1] |
| N-(4-Chlorophenyl)-2-[4-[(Z)-[1-(3-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 95.0 [1] |
| 2-[4-[(Z)-[1-(4-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-phenylacetamide | IC50 | 23.0 [1] |
| 2-[4-[(Z)-[1-(4-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-(2-methylphenyl)acetamide | IC50 | 32.0 [1] |
| 2-[4-[(Z)-[1-(4-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-(3-methylphenyl)acetamide | IC50 | 89.0 [1] |
| 2-[4-[(Z)-[1-(4-Methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]-N-(4-methylphenyl)acetamide | IC50 | 23.0 [1] |
| N-(2-Methoxyphenyl)-2-[4-[(Z)-[1-(4-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 43.0 [1] |
| N-(3-Methoxyphenyl)-2-[4-[(Z)-[1-(4-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 21.0 [1] |
| N-(4-Methoxyphenyl)-2-[4-[(Z)-[1-(4-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 23.0 [1] |
| N-(2-Chlorophenyl)-2-[4-[(Z)-[1-(4-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 24.0 [1] |
| N-(3-Chlorophenyl)-2-[4-[(Z)-[1-(4-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 35.0 [1] |
| N-(4-Chlorophenyl)-2-[4-[(Z)-[1-(4-methoxyphenyl)-5-oxo-2-phenylimidazol-4-ylidene]methyl]phenoxy]acetamide | IC50 | 47.0 [1] |
| 1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[2-methyl-4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea | IC50 | 3100.0 [1] |
| 3-(2-Methylpyridin-4-yl)-N-[(2,3,5-trichloropyridin-4-yl)methyl]-1H-indazole-5-carboxamide | IC50 | 16.7 [1] |
| N-[(3-Chlorophenyl)methyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 74.2 [1] |
| N-[1-(3-Chlorophenyl)ethyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 154.0 [1] |
| N-[1-(3-Chlorophenyl)propyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 78.7 [1] |
| N-[(1S)-1-(3-Chlorophenyl)-2-hydroxyethyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 26.3 [1] |
| N-[(1R)-1-(3-Chlorophenyl)-2-hydroxyethyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 833.0 [1] |
| N-[(1S)-1-(2,6-Dichlorophenyl)ethyl]-3-(2-methylpyridin-4-yl)-1H-indazole-5-carboxamide | IC50 | 19.4 [1] |
| N-[1-(2-Chlorophenyl)ethyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 35.9 [1] |
| N-[(2-Chlorophenyl)methyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 46.3 [1] |
| N-[(2,4-Dichloro-3-fluorophenyl)methyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 29.2 [1] |
| N-[1-(3-Chlorophenyl)-2-hydroxyethyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 72.4 [1] |
| N-[1-(3-Chlorophenyl)-2-hydroxyethyl]-3-(2-methylpyridin-4-yl)-1H-indazole-5-carboxamide | IC50 | 53.4 [1] |
| N-(3-Phenylpropyl)-3-pyridin-4-yl-1H-indazole-5-carboxamide | IC50 | 42.9 [1] |